To explore the effects of KPNB1 expression on the DDP sensitivity of melanoma cells, melanoma cells in each group were treated with 0, 4, 8, 16, 32, or 64 μM DDP, respectively, and then the half-maximal inhibitory concentration (IC50) value was calculated. The gene discussed is KPNB1; the disease is melanoma.